Zonula occludens-1 and HER-2/neu expression in invasive breast carcinoma

Applied Immunohistochemistry and Molecular Morphology

Volumn 11, Issue 2, 2003, Pages 125-129

  Bell, Julie ^a   Walsh, Shaun ^b   Nusrat, Asma ^b   Cohen, Cynthia ^b  

^a EMORY UNIVERSITY HOSPITAL   (United States)

^b NONE

Author keywords

Breast; HER 2 neu; Immunohistochemistry; Invasive carcinoma; ZO 1

Indexed keywords

BINDING PROTEIN; UNCLASSIFIED DRUG; ZONULA OCCLUDENS 1;

ARTICLE; BREAST CARCINOMA; CANCER INVASION; CONTROLLED STUDY; CORRELATION ANALYSIS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; ONCOGENE NEU; PRIORITY JOURNAL; PROMOTER REGION; SCORING SYSTEM;

EID: 0037899005     PISSN: 15412016     EISSN: None     Source Type: Journal    
DOI: 10.1097/00129039-200306000-00006     Document Type: Article

References (20)

1. Slamon DJ, Clark GM. Amplification of c-erb-B2 and aggressive breast tumors? Science. 1988;240:1795-8.
2. De Potter CR. The neu oncogene: more than a prognostic indicator? Hum Pathol. 1994;25:1264-8.
3. Ross JS, Fletcher JA. HER-2/neu (c-erb-B2) gene and protein in breast cancer. Am J Clin Pathol. 1999;112(suppl. 1):S53-67.
4. Revillion F, Bonneterre J, Peyrat JP. ErbB-2 oncogene in human breast cancer and its clinical significance. Eur J Cancer. 1998;34:791-808.
5. Cobleigh MA, Plante ML. Breast cancer: prognosis and prediction. Daily Summaries from the American Society of Clinical Oncology Annual Meeting. Day 3: May 22, 2000. Available at: http://www.medscape.com.
6. Hoang MP, Shain AA, Ordonez NG, et al. HER-2/neu gene amplification compared with HER-2/neu protein overexpression and interobserver reproducibility in invasive breast cancer. Am J Clin Pathol. 2000;113:852-9.
7. Jimenez RE, Wallis T, Tahasczka P, et al. Determination of HER-2/neu status in breast carcinomas: comparative analysis of immunohistochemistry and fluorescent in situ hybridization. Mod Pathol. 2000;13:37-45.
8. Couturier J, Vincent-Salomon A, Nicolas A, et al. Strong correlation between results of fluorescent in situ hybridization and immunohistochemistry for the assessment of ERBB2 (HER-2/neu) gene status in breast carcinoma. Mod Pathol. 2000;13:1238-43.
9. Wang S, Saboorian MH, Frenkel E, et al. Laboratory assessment of the status of Her-2/neu protein and oncogene in breast cancer specimens: comparison of immunohistochemistry assay with fluorescence in situ hybridization assays. Clin Pathol. 2000;53:374-81.
10. Karlan BY, Jones J, Slamon DJ, et al. Glucocorticoids stabilize HER-2/neu messenger RNA in human epithelial ovarian carcinoma cells. Gynecol Oncol. 1994;53:70-7.
11. Xing X, Wang SC, Xia W, et al. The ets protein PEA3 suppresses HER-2/neu overexpression and inhibits tumorigenesis. Nat Med. 2000;6:189-95.
12. Scott GK, Chang CH, Erny KM, et al. Ets regulation of the erbB2 promoter. Oncogene. 2000;19:6490-502.
13. Bosher JM, Totty NF, Hsuan JJ, et al. A family of AP-2 proteins regulates c-erb-2 expression in mammary carcinoma. Oncogene. 1996;13:1701-7.
14. Chen H, Hung MC. Involvement of co-activator p300 in the transcriptional regulation of the HER-2/neu gene. J Biol Chem. 1997;272:6101-4.
15. Yu D, Suen TC, Yan DH, et al. Transcriptional repression of the neu protooncogene by the adenovirus 5 E1A gene products. Proc Natl Acad Sci U S A. 1990;87:4499-503.
16. Gottardi CJ, Arpin M, Fanning AS, et al. The junction-associated protein, zonula occludens-1, localizes to the nucleus before the maturation and during the remodeling of cell-cell contacts. Cell Biol. 1996;93:10779-84.
17. Hoover KB, Liao S, Bryant PJ. Loss of the tight junction MAGUK ZO-1 in breast cancer. Am J Pathol. 1998;153:1767-73.
18. Gonzalez-Mariscal L, Betanzos A, Avila-Flores A. MAGUK proteins: structure and role in the tight junction. Semin Cell Dev Biol. 2000;11:315-24.
19. Balda MS, Matter K. The tight junction protein ZO-1 and an interacting transcription factor regulate erb-2 expression. Eur Mol Biol Org. 2000;19:2024-33.
20. Bloom HJG, Richardson WW. Histological grading and prognosis in breast cancer: a study of 1409 cases, of which 359 have been followed 15 years. Br J Cancer. 1957;11:359-77.